Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
Enfermedad de Parkinson
3833 ARTíCULOS , VIENDO DEL 2446 AL 2460
cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective
Dhapola R, Paidlewar M, Kumari S, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.
Int Immunopharmacol. 2025 Jun 26;159:114902. doi: 10.1016/j.intimp.2025.114902. Epub 2025 May 21.
0
0
0
Mitotherapy in Alzheimer's and Parkinson's diseases: A systematic review of preclinical studies
Modiri A, Hosseini L, Abolhasanpour N, Azizi H, Sadeh RN.
BMC Neurol. 2025 May 27;25(1):227. doi: 10.1186/s12883-025-04241-1.
0
0
0
Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
Sivalingam AM, Sureshkumar DD.
Mol Neurobiol. 2025 Jun;62(6):7576-7596. doi: 10.1007/s12035-025-04733-8. Epub 2025 Feb 7.
0
0
0
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression
Riederer P, Strobel S, Nagatsu T, Watanabe H, Chen X, Löschmann PA, Sian-Hulsmann J, Jost WH, Müller T, Dijkstra JM, Monoranu CM.
J Neural Transm (Vienna). 2025 Jun;132(6):743-779. doi: 10.1007/s00702-025-02893-4. Epub 2025 Apr 11.
0
0
0
Gene therapy for Parkinson's disease: trials and technical advances
Winston G, Kharas N, Svenningsson P, Jha A, Kaplitt MG.
Lancet Neurol. 2025 Jun;24(6):548-556. doi: 10.1016/S1474-4422(25)00125-5.
0
0
0
Carbidopa: beyond Parkinson's disease
Lenka A, Vernino S.
Clin Auton Res. 2025 Jun;35(3):347-352. doi: 10.1007/s10286-025-01122-y. Epub 2025 Mar 8.
0
0
0
Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology
Kathiresan DS, Balasubramani R, Marudhachalam K, Jaiswal P, Ramesh N, Sureshbabu SG, Puthamohan VM, Vijayan M.
Mol Neurobiol. 2025 Jun;62(6):6827-6855. doi: 10.1007/s12035-024-04469-x. Epub 2024 Sep 13.
0
0
0
Lau VZ, Awogbindin IO, Frenkel D, Whitehead SN, Tremblay MÈ.
Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.
0
0
0
Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine
Das S, Rajeswari VD, Venkatraman G, Ramanathan G.
Cell Biochem Biophys. 2025 Jun;83(2):1427-1443. doi: 10.1007/s12013-024-01607-z. Epub 2024 Nov 13.
0
0
0
Parkinson's disease: News on the action of melatonin
Scorza FA, Wuo-Silva R, Finsterer J, Chaddad-Neto F.
Sleep Med. 2025 Jun;130:1-2. doi: 10.1016/j.sleep.2025.02.038. Epub 2025 Feb 28.
0
0
0
Chronic Pain and Parkinson's Disease: Causation or Confounding?
Xu QH, Wang YL, Zhang BR, Tian J.
Mov Disord. 2025 Jun;40(6):1218-1219. doi: 10.1002/mds.30235. Epub 2025 May 23.
0
0
0
LRRK2-mediated mitochondrial dysfunction in Parkinson's disease
Buck SA, Sanders LH.
Biochem J. 2025 May 28;482(11):721-39. doi: 10.1042/BCJ20253062.
0
0
0
Neuromelanin and selective neuronal vulnerability to Parkinson's disease
Filimontseva A, Fu Y, Vila M, Halliday GM.
Trends Neurosci. 2025 Jun;48(6):445-459. doi: 10.1016/j.tins.2025.04.005. Epub 2025 May 6.
0
0
0
Fluid-based biomarkers for neurodegenerative diseases
Cao Y, Xu Y, Cao M, Chen N, Zeng Q, Lai MKP, Fan D, Sethi G, Cao Y.
Ageing Res Rev. 2025 Jun;108:102739. doi: 10.1016/j.arr.2025.102739. Epub 2025 Mar 21.
0
0
0
Pain and fatigue in Parkinson's disease: advances in diagnosis and management
Tinazzi M, Geroin C, Siciliano M, Gandolfi M, Di Vico I, De Micco R, Tessitore A.
Neurol Sci. 2025 Jun;46(6):2437-2454. doi: 10.1007/s10072-024-07985-9. Epub 2025 Feb 12.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
